These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 22015067)
1. [Management of herpes zoster neurotrophic ulcer using a new matrix therapy agent (RGTA): A case report]. De Monchy I; Labbé A; Pogorzalek N; Gendron G; M'Garrech M; Kaswin G; Labetoulle M J Fr Ophtalmol; 2012 Mar; 35(3):187.e1-6. PubMed ID: 22015067 [TBL] [Abstract][Full Text] [Related]
2. Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers. Aifa A; Gueudry J; Portmann A; Delcampe A; Muraine M Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8181-5. PubMed ID: 23150626 [TBL] [Abstract][Full Text] [Related]
4. Herpes zoster peripheral ulcerative keratitis in patients with the acquired immunodeficiency syndrome. Neves RA; Rodriguez A; Power WJ; Muccioli C; Lane L; Belfort R; Foster CS Cornea; 1996 Sep; 15(5):446-50. PubMed ID: 8862919 [TBL] [Abstract][Full Text] [Related]
5. Optic neuritis heralding varicella zoster virus retinitis in a patient with acquired immunodeficiency syndrome. Meenken C; van den Horn GJ; de Smet MD; van der Meer JT Ann Neurol; 1998 Apr; 43(4):534-6. PubMed ID: 9546338 [TBL] [Abstract][Full Text] [Related]
6. Peripheral corneal ulcers with herpes zoster ophthalmicus. Mondino BJ; Brown SI; Mondzelewski JP Am J Ophthalmol; 1978 Nov; 86(5):611-4. PubMed ID: 309729 [TBL] [Abstract][Full Text] [Related]
7. Neurotrophic Keratopathy: Therapeutic Approach Using a Novel Matrix Regenerating Agent. Guerra M; Marques S; Gil JQ; Campos J; Ramos P; Rosa AM; Quadrado MJ; Murta JN J Ocul Pharmacol Ther; 2017 Nov; 33(9):662-669. PubMed ID: 28910175 [TBL] [Abstract][Full Text] [Related]
8. Evaluation and management of herpes zoster ophthalmicus. Shaikh S; Ta CN Am Fam Physician; 2002 Nov; 66(9):1723-30. PubMed ID: 12449270 [TBL] [Abstract][Full Text] [Related]
9. Matrix Regeneration Therapy: A Case Series of Corneal Neurotrophic Ulcers. Arvola RP; Robciuc A; Holopainen JM Cornea; 2016 Apr; 35(4):451-5. PubMed ID: 26845313 [TBL] [Abstract][Full Text] [Related]
10. Healing of resistant corneal neurotrophic ulcers using a matrix regenerating agent. Cochener B; Zagnoli C; Hugny-Larroque C; Derrien S J Fr Ophtalmol; 2019 Feb; 42(2):159-165. PubMed ID: 30573293 [TBL] [Abstract][Full Text] [Related]
11. Presumed bilateral herpes zoster ophthalmicus in an AIDS patient: a case report. Yau TH; Butrus SI Cornea; 1996 Nov; 15(6):633-4. PubMed ID: 8899277 [TBL] [Abstract][Full Text] [Related]
12. [Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy]. Chebbi CK; Kichenin K; Amar N; Nourry H; Warnet JM; Barritault D; Baudouin C J Fr Ophtalmol; 2008 May; 31(5):465-71. PubMed ID: 18641578 [TBL] [Abstract][Full Text] [Related]
13. Treatment of spontaneous corneal perforation secondary to undiagnosed Sjögren's syndrome using regenerating agent and autologous serum eye drops. Tzamalis A; Matsou A; Anastasopoulos E; Ziakas N Eur J Ophthalmol; 2021 Jan; 31(1):NP17-NP21. PubMed ID: 31137968 [TBL] [Abstract][Full Text] [Related]
14. Herpes zoster stromal keratitis after varicella vaccine booster in a pediatric patient. Krall P; Kubal A Cornea; 2014 Sep; 33(9):988-9. PubMed ID: 25062334 [TBL] [Abstract][Full Text] [Related]
16. [Bilateral acute retinal artery necrosis--healing of the second affected eye]. Kalman A; Vogt M; Bernasconi E; Gloor B Klin Monbl Augenheilkd; 1994 Apr; 204(4):235-40. PubMed ID: 8022154 [TBL] [Abstract][Full Text] [Related]
17. [Antiviral drug therapy of infections caused by Herpes simplex and Varicella Zoster viruses]. Vogt M; Huss R; Wunderli W Schweiz Med Wochenschr; 1992 Apr; 122(16):569-75. PubMed ID: 1579862 [TBL] [Abstract][Full Text] [Related]